The vaporiser can be used as a handheld device. Credit: GlobeNewswire/Thornhill Medical.

Canadian medical technology manufacturer Thornhill Medical is planning to boost production of MADM, a mobile gas anaesthesia technology.

The portable inline direct injection gas vaporiser, which received approvals from both the US Food and Drug Administration and Health Canada, is designed to easily connect to any ventilator for easily delivering isoflurane and sevoflurane gas anaesthesia.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Said to be easy to use due to its small footprint, the lightweight technology features compact design making it ideal in more challenging environments such as forward-deployed surgical scenarios and field hospitals.

The vaporiser can easily be hand-carried or attached to Thornhill’s MOVES SLC integrated life-support system to stand up a forward surgical capability quickly.

Thornhill president and CEO Lesley Gouldie said: “We know that surgical care in the far-forward setting needs solutions that promote agility, mobility and are self-sufficient while overcoming contested logistics and supply chain interruptions.

“We are also experiencing an increased demand for our MOVES SLC integrated life-support system which is why it is imperative that we are ready to support our combat and humanitarian partners to help save more lives with our companion MADM technology.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The technology was initially developed with the US Marine Corps as its field anaesthesia system. It has been deployed in critical care scenarios, including in Ukraine.

Capable of automatically adapting its operation to any ventilator type it is connected, the technology has been assessed for field use by the US Army Aeromedical Research Laboratory and Air Force Medical Evaluation Support Activity.